You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Endothelial Progenitor Cells

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Acute Ischemic Stroke Trial in Beijing (iEPCs, Clinical standard treatment (CST))

Not yet recruiting
  • Acute Ischemic Stroke
  • iEPCs
  • Clinical standard treatment (CST)
  • Beijing, Beijing, China
    Allife
Aug 14, 2023

Endothelial Dysfunction, Diabetes, Type 1, Biomarkers Trial in Celje (Semaglutide Pen Injector [Ozempic], Empagliflozin 10 MG)

Completed
  • Endothelial Dysfunction
  • +9 more
  • Semaglutide Pen Injector [Ozempic]
  • Empagliflozin 10 MG
  • Celje, Slovenia
    General Hospital Celje
May 10, 2023

Aging, Exercise, Cardiovascular Disease Trial in Baltimore (Exercise Training, Exercise Cessation)

Active, not recruiting
  • Aging
  • +2 more
  • Exercise Training
  • Exercise Cessation
  • Baltimore, Maryland
    University of Maryland, Baltimore & Baltimore VA Medical Center
Feb 28, 2022

Diabetes, Type 2, Cardiovascular Diseases Trial in Washington (Dapagliflozin 10mg, Saxagliptin 5mg, Placebo Oral Tablet)

Terminated
  • Diabetes Mellitus, Type 2
  • Cardiovascular Diseases
  • Dapagliflozin 10mg
  • +2 more
  • Washington, District of Columbia
    The GW Medical Faculty Associates
Mar 21, 2022

Type 2 Diabetes Trial in Baltimore (Aerobic Exercise Training)

Active, not recruiting
  • Type 2 Diabetes Mellitus
  • Aerobic Exercise Training
  • Baltimore, Maryland
    Baltimore VA Medical Center
Feb 28, 2022

Healthy Trial in Danderyd (Electronic cigarette)

Completed
  • Healthy
  • Electronic cigarette
  • Danderyd, Stockholm, Sweden
    Institutionen för kliniska vetenskaper, Danderyds sjukhus
Oct 8, 2021

Stable Coronary Artery Disease Trial in Pavia (Atorvastatin)

Terminated
  • Stable Coronary Artery Disease
  • Pavia, Italy
    Fondazione Irccs Policlinico San Matteo
Aug 30, 2021

Endothelial Progenitor Cells, Coronary Artery Disease, Vascular Injury Trial in Edinburgh (Administration of radio labelled

Completed
  • Endothelial Progenitor Cells
  • +3 more
  • Administration of radio labelled endothelial outgrowth cells
  • Edinburgh, Midlothian, United Kingdom
    University of Edinburgh
Jul 15, 2021

Stroke Trial in Guangzhou (Intravenous stem cell transplantation)

Completed
  • Stroke
  • Intravenous stem cell transplantation
  • Guangzhou, Guangdong, China
    Zhujiang Hospital, Southern Medical University
Apr 1, 2021

Stroke, Infarction, Middle Cerebral Artery Trial in Guangzhou (Autologous BMSCs transplantation, Autologous EPCs

Completed
  • Stroke
  • Infarction, Middle Cerebral Artery
  • Autologous BMSCs transplantation
  • +2 more
  • Guangzhou, Guangdong, China
    Zhujiang Hospital, Southern Medical University
Apr 1, 2021

End Stage Liver Disease Trial in Singapore (GCSF, CD133 Cells Transplantation)

Recruiting
  • End Stage Liver Disease
  • GCSF
  • CD133 Cells Transplantation
  • Singapore, Singapore
    National University Hospital
Jan 14, 2021

Endothelial Dysfunction and MACES in Population With Acute

Completed
  • Endothelial Dysfunction
  • +2 more
    • Mexico City, Mexico
      National Medical Center "20 de Noviembre", ISSSTE
    Mar 1, 2021

    Type 2 Diabetes Trial in Mobile (pre-bariatric weight loss program, bariatric surgery)

    Completed
    Has Results
    • Type 2 Diabetes
    • pre-bariatric weight loss program
    • bariatric surgery
    • Mobile, Alabama
      University of South Alabama
    Nov 18, 2020

    Kidney Diseases Trial (endothelial progenitor cell)

    Not yet recruiting
    • Kidney Diseases
    • endothelial progenitor cell
    • (no location specified)
    Jul 25, 2022

    Heart Failure With Reduced Ejection Fraction Trial (Extracellular vesicle-enriched secretome of cardiovascular progenitor cells

    Not yet recruiting
    • Heart Failure With Reduced Ejection Fraction
    • Extracellular vesicle-enriched secretome of cardiovascular progenitor cells differentiated from induced pluripotent stem cells
    • (no location specified)
    Mar 7, 2023

    Vascular Endothelial Growth Factor and Endostatin in

    Completed
    • Acute Ischemic Stroke
      • Shanghai, China
        Shanghai Sixth People's Hospital
      Aug 8, 2020

      Blood Endothelium Progenitor Cells and Dendritic Cells as

      Completed
      • Atherosclerosis
      • Restenosis
        • Edegem, Antwerpen, Belgium
          Universitair Ziekenhuis Antwerpen
        Nov 3, 2022

        Gingival Recession, Lack of Keratinized Gingiva (Disorder) Trial in Birmingham (progenitor potential of Gingival Mesenchymal

        Active, not recruiting
        • Gingival Recession
        • Lack of Keratinized Gingiva (Disorder)
        • progenitor potential of Gingival Mesenchymal cells
        • Birmingham, Alabama
          UAB School of Dentistry Department of Periodontology
        Jan 5, 2023

        Kidney Diseases, Endothelial Dysfunction Trial in Boston (Cell isolation)

        Withdrawn
        • Kidney Diseases
        • Endothelial Dysfunction
        • Cell isolation
        • Boston, Massachusetts
          Brigham and Women's Hospital
        Jul 31, 2022

        Knee Osteoarthritis Trial in Shanghai, Beijing, Hangzhou (Mesenchymal progenitor cells, Sodium Hyaluronate Injection)

        Not yet recruiting
        • Knee Osteoarthritis
        • Mesenchymal progenitor cells
        • Sodium Hyaluronate Injection
        • Shanghai, Shanghai, China
        • +5 more
        Aug 9, 2023

        (LTFU) of Patients Treated With Genome-edited Autologous

        Not yet recruiting
        • Sickle Cell Disease
        • OTQ923
        • (no location specified)
        Nov 24, 2023

        SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors Trial in Frankfurt

        Withdrawn
        • SDF-1 is an Important Cytokine for Neovascularization. Cleavage of SDF-1 is Reduced by DPPIV Inhibitors
        • Frankfurt, Germany
          Department of Cardiology
        Aug 31, 2020

        Anterior Wall Myocardial Infarction Trial in Canada (Plasma-Lyte A and 25% Autologous Plasma, Autologous EPCs, Autologous EPCs

        Active, not recruiting
        • Anterior Wall Myocardial Infarction
        • Plasma-Lyte A and 25% Autologous Plasma
        • +2 more
        • Ottawa, Ontario, Canada
        • +3 more
        Dec 1, 2020

        The Viability Control of Human Endothelial Cells Before

        Not yet recruiting
        • Corneal Transplant Failure
        • Corneal Endothelial Cell Loss
        • V-Check
        • Brescia, BS, Italy
          Azienda Socio Sanitaria Territoriale degli Spedali Civili di Bre
        Apr 27, 2023

        Retinitis Pigmentosa Trial in Irvine, Los Angeles, Boston (human retinal progenitor cells)

        Completed
        • Retinitis Pigmentosa
        • human retinal progenitor cells
        • Irvine, California
        • +2 more
        Aug 8, 2022